Chesi M - Search Results

1

BET bromodomain inhibition as a therapeutic strategy to target c-Myc.

Delmore JE, Issa GC, Lemieux ME, Rahl PB, Shi J, Jacobs HM, Kastritis E, Gilpatrick T, Paranal RM, Qi J, Chesi M, Schinzel AC, McKeown MR, Heffernan TP, Vakoc CR, Bergsagel PL, Ghobrial IM, Richardson PG, Young RA, Hahn WC, Anderson KC, Kung AL, Bradner JE, Mitsiades CS. Delmore JE, et al. Among authors: chesi m. Cell. 2011 Sep 16;146(6):904-17. doi: 10.1016/j.cell.2011.08.017. Epub 2011 Sep 1. Cell. 2011. PMID: 21889194 Free PMC article.

2

Genomic Classification and Individualized Prognosis in Multiple Myeloma.

Maura F, Rajanna AR, Ziccheddu B, Poos AM, Derkach A, Maclachlan K, Durante M, Diamond B, Papadimitriou M, Davies F, Boyle EM, Walker B, Hultcrantz M, Silva A, Hampton O, Teer JK, Siegel EM, Bolli N, Jackson GH, Kaiser M, Pawlyn C, Cook G, Kazandjian D, Stein C, Chesi M, Bergsagel L, Mai EK, Goldschmidt H, Weisel KC, Fenk R, Raab MS, Van Rhee F, Usmani S, Shain KH, Weinhold N, Morgan G, Landgren O. Maura F, et al. Among authors: chesi m. J Clin Oncol. 2024 Apr 10;42(11):1229-1240. doi: 10.1200/JCO.23.01277. Epub 2024 Jan 9. J Clin Oncol. 2024. PMID: 38194610

3

Dysregulation of cyclin D1 by translocation into an IgH gamma switch region in two multiple myeloma cell lines.

Chesi M, Bergsagel PL, Brents LA, Smith CM, Gerhard DS, Kuehl WM. Chesi M, et al. Blood. 1996 Jul 15;88(2):674-81. Blood. 1996. PMID: 8695815 Free article.

4

Selective expression of one c-myc allele in two human myeloma cell lines.

Kuehl WM, Brents LA, Chesi M, Bergsagel PL. Kuehl WM, et al. Among authors: chesi m. Cancer Res. 1996 Oct 1;56(19):4370-3. Cancer Res. 1996. PMID: 8813127

5

Frequent translocation t(4;14)(p16.3;q32.3) in multiple myeloma is associated with increased expression and activating mutations of fibroblast growth factor receptor 3.

Chesi M, Nardini E, Brents LA, Schröck E, Ried T, Kuehl WM, Bergsagel PL. Chesi M, et al. Nat Genet. 1997 Jul;16(3):260-4. doi: 10.1038/ng0797-260. Nat Genet. 1997. PMID: 9207791 Free PMC article.

6

Dysregulation of c-myc in multiple myeloma.

Kuehl WM, Brents LA, Chesi M, Huppi K, Bergsagel PL. Kuehl WM, et al. Among authors: chesi m. Curr Top Microbiol Immunol. 1997;224:277-82. doi: 10.1007/978-3-642-60801-8_29. Curr Top Microbiol Immunol. 1997. PMID: 9308252

7

IgH translocations in multiple myeloma: a nearly universal event that rarely involves c-myc.

Bergsagel PL, Nardini E, Brents L, Chesi M, Kuehl WM. Bergsagel PL, et al. Among authors: chesi m. Curr Top Microbiol Immunol. 1997;224:283-7. doi: 10.1007/978-3-642-60801-8_30. Curr Top Microbiol Immunol. 1997. PMID: 9308253

8

Frequent dysregulation of the c-maf proto-oncogene at 16q23 by translocation to an Ig locus in multiple myeloma.

Chesi M, Bergsagel PL, Shonukan OO, Martelli ML, Brents LA, Chen T, Schröck E, Ried T, Kuehl WM. Chesi M, et al. Blood. 1998 Jun 15;91(12):4457-63. Blood. 1998. PMID: 9616139 Free article.

9

The t(4;14) translocation in myeloma dysregulates both FGFR3 and a novel gene, MMSET, resulting in IgH/MMSET hybrid transcripts.

Chesi M, Nardini E, Lim RS, Smith KD, Kuehl WM, Bergsagel PL. Chesi M, et al. Blood. 1998 Nov 1;92(9):3025-34. Blood. 1998. PMID: 9787135 Free article.

10

Insertion of excised IgH switch sequences causes overexpression of cyclin D1 in a myeloma tumor cell.

Gabrea A, Bergsagel PL, Chesi M, Shou Y, Kuehl WM. Gabrea A, et al. Among authors: chesi m. Mol Cell. 1999 Jan;3(1):119-23. doi: 10.1016/s1097-2765(00)80180-x. Mol Cell. 1999. PMID: 10024885 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

108 results

Search Page